{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:28:35Z","timestamp":1791815315060,"version":"4.3.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Major depressive disorder is highly prevalent worldwide and has been affecting an increasing number of people each year. Current first line antidepressants show merely 37% remission, and physicians are forced to use a trial-and-error approach when choosing a single antidepressant out of dozens of available medications. We sought to identify a method of testing that would provide patient-specific information on whether a patient will respond to a medication using in vitro modeling. Patient-derived lymphoblastoid cell lines from the Sequenced Treatment Alternatives to Relieve Depression study were used to rapidly generate cortical neurons and screen them for bupropion effects, for which the donor patients showed remission or non-remission. We provide evidence for biomarkers specific for bupropion response, including synaptic connectivity and morphology changes as well as specific gene expression alterations. These biomarkers support the concept of personalized antidepressant treatment based on in vitro platforms and could be utilized as predictors to patient response in the clinic.<\/jats:p>","DOI":"10.1038\/s41398-021-01319-5","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T16:03:42Z","timestamp":1617293022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Depression patient-derived cortical neurons reveal potential biomarkers for antidepressant response"],"prefix":"10.1038","volume":"11","author":[{"given":"Yishai","family":"Avior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiri","family":"Ron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Kroitorou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Albeldas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitaly","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5189-6749","authenticated-orcid":false,"given":"Barbara","family":"Corneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6184-4202","authenticated-orcid":false,"given":"Erez","family":"Nitzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphna","family":"Laifenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9525-5732","authenticated-orcid":false,"given":"Talia","family":"Cohen Solal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"1319_CR1","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators.","year":"2018","unstructured":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1789\u20131858 (2018).","journal-title":"Lancet"},{"key":"1319_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001547","volume":"10","author":"AJ Ferrari","year":"2013","unstructured":"Ferrari, A. J. et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 10, e1001547 (2013).","journal-title":"PLoS Med."},{"key":"1319_CR3","first-page":"5","volume":"17","author":"HA Nasrallah","year":"2018","unstructured":"Nasrallah, H. A. Psychopharmacology 3.0. Curr. Psychiatr. 17, 5\u20137 (2018).","journal-title":"Curr. Psychiatr."},{"key":"1319_CR4","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1177\/070674371005500303","volume":"55","author":"M Sinyor","year":"2010","unstructured":"Sinyor, M., Schaffer, A. & Levitt, A. The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: a review. Can. J. Psychiatry 55, 126\u2013135 (2010).","journal-title":"Can. J. Psychiatry"},{"key":"1319_CR5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1001\/archpsyc.57.4.349","volume":"57","author":"G Rosoklija","year":"2000","unstructured":"Rosoklija, G. et al. Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch. Gen. Psychiatry 57, 349\u2013356 (2000).","journal-title":"Arch. Gen. Psychiatry"},{"key":"1319_CR6","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1046\/j.1471-4159.2002.01215.x","volume":"83","author":"D Laifenfeld","year":"2002","unstructured":"Laifenfeld, D., Klein, E. & Ben-Shachar, D. Norepinephrine alters the expression of genes involved in neuronal sprouting and differentiation: relevance for major depression and antidepressant mechanisms. J. Neurochem. 83, 1054\u20131064 (2002).","journal-title":"J. Neurochem."},{"key":"1319_CR7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00213-010-1881-0","volume":"213","author":"JW Murrough","year":"2011","unstructured":"Murrough, J. W. et al. Reduced ventral striatal\/ventral pallidal serotonin1B receptor binding potential in major depressive disorder. Psychopharmacology 213, 547\u2013553 (2011).","journal-title":"Psychopharmacology"},{"key":"1319_CR8","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/nm.2886","volume":"18","author":"HJ Kang","year":"2012","unstructured":"Kang, H. J. et al. Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nat. Med. 18, 1413\u20131417 (2012).","journal-title":"Nat. Med."},{"key":"1319_CR9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.biopsych.2013.12.005","volume":"76","author":"CL McGrath","year":"2014","unstructured":"McGrath, C. L. et al. Pretreatment brain states identify likely nonresponse to standard treatments for depression. Biol. Psychiatry 76, 527\u2013535 (2014).","journal-title":"Biol. Psychiatry"},{"key":"1319_CR10","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/nature13716","volume":"515","author":"Z Wen","year":"2014","unstructured":"Wen, Z. et al. Synaptic dysregulation in a human iPS cell model of mental disorders. Nature 515, 414\u2013418 (2014).","journal-title":"Nature"},{"key":"1319_CR11","doi-asserted-by":"crossref","unstructured":"Vadodaria, K. C. et al. Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons. Mol. Psychiatry. (2019).","DOI":"10.1038\/s41380-019-0363-y"},{"key":"1319_CR12","doi-asserted-by":"crossref","unstructured":"Malhi, G. S. & Mann, J. J. Depression. Lancet. (2018).","DOI":"10.1016\/S0140-6736(18)31948-2"},{"key":"1319_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.pnpbp.2017.04.008","volume":"77","author":"Q Wang","year":"2017","unstructured":"Wang, Q., Timberlake, M. A., Prall, K. & Dwivedi, Y. The recent progress in animal models of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 77, 99\u2013109 (2017).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"1319_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nrm.2015.27","volume":"17","author":"Y Avior","year":"2016","unstructured":"Avior, Y., Sagi, I. & Benvenisty, N. Pluripotent stem cells in disease modelling and drug discovery. Nat. Rev. Mol. Cell Biol. 17, 170\u2013182 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1319_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nature15526","volume":"527","author":"J Mertens","year":"2015","unstructured":"Mertens, J. et al. Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder. Nature 527, 95\u201399 (2015).","journal-title":"Nature"},{"key":"1319_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09915","volume":"473","author":"KJ Brennand","year":"2011","unstructured":"Brennand, K. J. et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 473, 221\u2013225 (2011).","journal-title":"Nature"},{"key":"1319_CR17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/mp.2011.13","volume":"16","author":"C-H Chiang","year":"2011","unstructured":"Chiang, C.-H. et al. Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol. Psychiatry 16, 358\u2013360 (2011).","journal-title":"Mol. Psychiatry"},{"key":"1319_CR18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/mp.2015.101","volume":"21","author":"Z Xu","year":"2016","unstructured":"Xu, Z. et al. Direct conversion of human fibroblasts to induced serotonergic neurons. Mol. Psychiatry 21, 62\u201370 (2016).","journal-title":"Mol. Psychiatry"},{"key":"1319_CR19","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.celrep.2018.06.091","volume":"24","author":"M D\u2019Antonio","year":"2018","unstructured":"D\u2019Antonio, M. et al. Insights into the mutational burden of human induced pluripotent stem cells from an integrative multi-omics approach. Cell Rep. 24, 883\u2013894 (2018).","journal-title":"Cell Rep."},{"key":"1319_CR20","doi-asserted-by":"crossref","unstructured":"McCaughey-Chapman, A. & Connor, B. Human cortical neuron generation using cell reprogramming: a review of recent advances. Stem. Cells Dev. (2018).","DOI":"10.1089\/scd.2018.0122"},{"key":"1319_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0197-2456(03)00112-0","volume":"25","author":"AJ Rush","year":"2004","unstructured":"Rush, A. J. et al. Sequenced Treatment Alternatives to Relieve Depression (STAR*D): rationale and design. Control. Clin. Trials 25, 119\u2013142 (2004).","journal-title":"Control. Clin. Trials"},{"key":"1319_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","volume":"163","author":"MH Trivedi","year":"2006","unstructured":"Trivedi, M. H. et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am. J. Psychiatry 163, 28\u201340 (2006).","journal-title":"Am. J. Psychiatry"},{"key":"1319_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/nbt.3777","volume":"35","author":"Y Qi","year":"2017","unstructured":"Qi, Y. et al. Combined small-molecule inhibition accelerates the derivation of functional cortical neurons from human pluripotent stem cells. Nat. Biotechnol. 35, 154\u2013163 (2017).","journal-title":"Nat. Biotechnol."},{"key":"1319_CR24","doi-asserted-by":"crossref","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics (2013).","DOI":"10.1093\/bioinformatics\/bts635"},{"key":"1319_CR25","doi-asserted-by":"crossref","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics (2009).","DOI":"10.1093\/bioinformatics\/btp616"},{"key":"1319_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"key":"1319_CR27","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1007\/s12035-019-01839-8","volume":"57","author":"D Cohen-Carmon","year":"2020","unstructured":"Cohen-Carmon, D. et al. Progerin-induced transcriptional changes in Huntington\u2019s disease human pluripotent stem cell-derived neurons. Mol. Neurobiol. 57, 1768\u20131777 (2020).","journal-title":"Mol. Neurobiol."},{"key":"1319_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","volume":"54","author":"AJ Rush","year":"2003","unstructured":"Rush, A. J. et al. The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol. Psychiatry 54, 573\u2013583 (2003).","journal-title":"Biol. Psychiatry"},{"key":"1319_CR29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.stem.2012.01.021","volume":"10","author":"L Ma","year":"2012","unstructured":"Ma, L. et al. Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice. Cell Stem Cell 10, 455\u2013464 (2012).","journal-title":"Cell Stem Cell"},{"key":"1319_CR30","doi-asserted-by":"crossref","unstructured":"Harris, M. & Jensen, E. Three-dimensional structure of dendritic spines and synapses in rat hippocampus (CA1) at postnatal day 15 and adult ages. J. Neurosci. (1992).","DOI":"10.1523\/JNEUROSCI.12-07-02685.1992"},{"key":"1319_CR31","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1085\/jgp.201812261","volume":"151","author":"M Bell","year":"2019","unstructured":"Bell, M., Bartol, T., Sejnowski, T. & Rangamani, P. Dendritic spine geometry and spine apparatus organization govern the spatiotemporal dynamics of calcium. J. Gen. Physiol. 151, 1017\u20131034 (2019).","journal-title":"J. Gen. Physiol."},{"key":"1319_CR32","doi-asserted-by":"publisher","first-page":"768391","DOI":"10.1155\/2014\/768391","volume":"2014","author":"S Raab","year":"2014","unstructured":"Raab, S., Klingenstein, M., Liebau, S. & Linta, L. A comparative view on human somatic cell sources for iPSC generation. Stem Cells Int. 2014, 768391 (2014).","journal-title":"Stem Cells Int."},{"key":"1319_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005793","volume":"12","author":"CK Burrows","year":"2016","unstructured":"Burrows, C. K. et al. Genetic variation, not cell type of origin, underlies the majority of identifiable regulatory differences in iPSCs. PLoS Genet. 12, e1005793 (2016).","journal-title":"PLoS Genet."},{"key":"1319_CR34","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.5966\/sctm.2014-0121","volume":"3","author":"R Barrett","year":"2014","unstructured":"Barrett, R. et al. Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines. Stem Cells Transl. Med. 3, 1429\u20131434 (2014).","journal-title":"Stem Cells Transl. Med."},{"key":"1319_CR35","doi-asserted-by":"crossref","unstructured":"Gore, A. et al. Somatic coding mutations in human induced pluripotent stem cells. Nature (2011).","DOI":"10.1038\/nature09805"},{"key":"1319_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-018-3664-3","volume":"11","author":"LB Scheinfeldt","year":"2018","unstructured":"Scheinfeldt, L. B. et al. Genetic and genomic stability across lymphoblastoid cell line expansions. BMC Res. Notes 11, 558 (2018).","journal-title":"BMC Res. Notes"},{"key":"1319_CR37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4161\/epi.4.3.8793","volume":"4","author":"EP Brennan","year":"2009","unstructured":"Brennan, E. P. et al. Comparative analysis of DNA methylation profiles in peripheral blood leukocytes versus lymphoblastoid cell lines. Epigenetics 4, 159\u2013164 (2009).","journal-title":"Epigenetics"},{"key":"1319_CR38","doi-asserted-by":"publisher","first-page":"508","DOI":"10.4161\/epi.6.4.14876","volume":"6","author":"H Sugawara","year":"2011","unstructured":"Sugawara, H. et al. Comprehensive DNA methylation analysis of human peripheral blood leukocytes and lymphoblastoid cell lines. Epigenetics 6, 508\u2013515 (2011).","journal-title":"Epigenetics"},{"key":"1319_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/2045125316629071","volume":"6","author":"K Patel","year":"2016","unstructured":"Patel, K. et al. Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant. Ther. Adv. Psychopharmacol. 6, 99\u2013144 (2016).","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"1319_CR40","doi-asserted-by":"crossref","unstructured":"Nieuwstraten, C. E. & Dolovich, L. R. Bupropion versus selective serotonin-reuptake inhibitors for treatment of depression. Ann. Pharmacother. (2001).","DOI":"10.1345\/aph.1A099"},{"key":"1319_CR41","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/s41562-019-0732-1","volume":"3","author":"GA Fonzo","year":"2019","unstructured":"Fonzo, G. A. et al. Brain regulation of emotional conflict predicts antidepressant treatment response for depression. Nat. Hum. Behav. 3, 1319\u20131331 (2019).","journal-title":"Nat. Hum. Behav."},{"key":"1319_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-019-1072-6","volume":"21","author":"K Dunlop","year":"2019","unstructured":"Dunlop, K., Talishinsky, A. & Liston, C. Intrinsic brain network biomarkers of antidepressant response: a review. Curr. Psychiatry Rep. 21, 87 (2019).","journal-title":"Curr. Psychiatry Rep."},{"key":"1319_CR43","first-page":"566","volume":"2","author":"CG Abdallah","year":"2017","unstructured":"Abdallah, C. G. et al. Prefrontal connectivity and glutamate transmission: relevance to depression pathophysiology and ketamine treatment. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 2, 566\u2013574 (2017).","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"1319_CR44","doi-asserted-by":"crossref","unstructured":"Murrough, J. W. et al. Reduced global functional connectivity of the medial prefrontal cortex in major depressive disorder. Hum. Brain Mapp. (2016).","DOI":"10.1002\/hbm.23235"},{"key":"1319_CR45","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/ijnp\/pyx016","volume":"20","author":"E Rzepa","year":"2017","unstructured":"Rzepa, E., Dean, Z. & McCabe, C. Bupropion administration increases resting-state functional connectivity in dorso-medial prefrontal cortex. Int. J. Neuropsychopharmacol. 20, 455\u2013462 (2017).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"1319_CR46","doi-asserted-by":"crossref","unstructured":"Bourne, J. & Harris, K. M. Do thin spines learn to be mushroom spines that remember? Curr. Opin. Neurobiol. (2007).","DOI":"10.1016\/j.conb.2007.04.009"},{"key":"1319_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60118-y","volume":"10","author":"H Jiang","year":"2020","unstructured":"Jiang, H. et al. Live neuron high-content screening reveals synaptotoxic activity in alzheimer mouse model homogenates. Sci. Rep. 10, 3412 (2020).","journal-title":"Sci. Rep."},{"key":"1319_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035367","volume":"7","author":"A Sequeira","year":"2012","unstructured":"Sequeira, A. et al. Gene expression changes in the prefrontal cortex, anterior cingulate cortex and nucleus accumbens of mood disorders subjects that committed suicide. PLoS ONE 7, e35367 (2012).","journal-title":"PLoS ONE"},{"key":"1319_CR49","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/npp.2008.76","volume":"34","author":"A Surget","year":"2009","unstructured":"Surget, A. et al. Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal. Neuropsychopharmacology 34, 1363\u20131380 (2009).","journal-title":"Neuropsychopharmacology"},{"key":"1319_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/srep18776","volume":"6","author":"H Hori","year":"2016","unstructured":"Hori, H. et al. Blood-based gene expression signatures of medication-free outpatients with major depressive disorder: integrative genome-wide and candidate gene analyses. Sci. Rep. 6, 18776 (2016).","journal-title":"Sci. Rep."},{"key":"1319_CR51","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jad.2015.05.067","volume":"184","author":"CD Wiener","year":"2015","unstructured":"Wiener, C. D. et al. Serum levels of nerve growth factor (NGF) in patients with major depression disorder and suicide risk. J. Affect Disord. 184, 245\u2013248 (2015).","journal-title":"J. Affect Disord."},{"key":"1319_CR52","doi-asserted-by":"crossref","unstructured":"Zhang, X., Li, J., Sha, W. & Bu, R. Neurotrophic factors and major depressive disorder. in Major Depressive Disorder\u2014Cognitive and Neurobiological Mechanisms, Vol. 2015, pp 21\u201348 (2015).","DOI":"10.5772\/59373"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01319-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01319-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01319-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T12:53:57Z","timestamp":1669899237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01319-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["1319"],"URL":"https:\/\/doi.org\/10.1038\/s41398-021-01319-5","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"assertion":[{"value":"1 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.A., D.K., E.N., C.A., D.L., and T.C.S. are employees of GenetikaPlus Ltd and received salary and\/or stock options for the submitted work. S.R. is a former employee of GenetikaPlus Ltd and received salary during the conduct of the study. V.L. and B.C. are consultants of GenetikaPlus Ltd and received financial compensation during the conduct of the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"201"}}